| Calretinin |
|---|
| Protein Name | Calretinin |
| Gene | CALB2 |
| UniProt ID | P22676 |
| PDB ID | 1T5L |
| Molecular Weight | 31 kDa |
| Localization | Cytosol |
| Protein Family | EF-hand calcium-binding proteins |
Calretinin (encoded by the CALB2 gene) is a calcium-binding protein belonging to the EF-hand family of proteins. It contains 6 EF-hand motifs and has a molecular weight of approximately 31 kDa. Calretinin is primarily expressed in specific populations of GABAergic interneurons throughout the central nervous system, particularly in the cortex, hippocampus, and cerebellum.
Calretinin serves as a reliable immunohistochemical marker for identifying specific interneuron subsets due to its highly restricted expression pattern. It is considered a calcium buffer with high affinity for calcium ions.
Calretinin possesses six EF-hand calcium-binding motifs:
- Five functional EF-hands capable of binding calcium
- High-affinity calcium binding properties
- Protein structure stabilized by hydrophobic core interactions
- Dimerization capability under certain conditions
The three-dimensional structure has been solved (PDB: 1T5L), revealing the characteristic EF-hand fold common to all calcium-binding proteins in this family.
Calretinin functions as a high-affinity calcium buffer in neurons:
- Protects neurons from calcium overload
- Modulates calcium signaling kinetics
- Shapes synaptic plasticity
Calretinin is expressed in specific interneuron populations:
Calretinin modulates synaptic transmission:
- Influences GABA release
- Affects postsynaptic calcium dynamics
- May play roles in network oscillations
Calretinin-expressing neurons show notable resilience in Alzheimer's disease:
- Calretinin-positive ([CR+] interneurons](/cell-types/calretinin-interneurons) are relatively preserved compared to other interneuron populations
- These neurons may be resistant to amyloid toxicity
- Potential protective mechanisms include:
- Enhanced calcium homeostasis
- Lower metabolic demands
- Distinctive electrophysiological properties
The relative preservation of CR+ neurons makes them of interest for understanding selective vulnerability in neurodegeneration.
Calretinin expression in Parkinson's disease:
- Altered expression patterns observed in some studies
- Potential involvement in basal ganglia circuitry
- May affect dopaminergic neuron function
Calretinin alterations in schizophrenia:
- Changes in CR+ neuron density reported
- Potential role in circuit dysfunction
- Linked to gamma oscillation abnormalities
- Huntington's Disease: Variable expression changes
- Epilepsy: Altered calretinin in seizure contexts
- Autism Spectrum Disorders: Some studies report differences
Calretinin has attracted attention for therapeutic development:
- Neuroprotective Strategies: Understanding why CR+ neurons resist degeneration could inform protective therapies
- Cell Replacement Therapy: CR+ interneurons as candidates for cell-based therapies
- Biomarker Potential: Calretinin as a marker for specific neuron populations in disease states
Calretinin is widely used in research:
- Immunohistochemistry: Primary marker for CR+ neurons
- Transgenic Models: Reporter lines for studying interneuron populations
- Single-cell RNA-seq: Marker gene for interneuron classification
- Rogers et al. (1988). Calretinin: a calcium-binding protein in the CNS. J Neurosci.
- Schwaller et al. (2002). Calretinin, calbindin D-28k and parvalbumin in the rat peripheral nervous system. Neuroscience.
- Gulyás et al. (1996). Calretinin is present in GABA-containing non-pyramidal cells of the rat hippocampus. Hippocampus.
- Ferrer et al. (1994). Calretinin in neurodegenerative processes. J Neural Transm Suppl.
- Hof et al. (1999). Calretinin-immunoreactive neurons and their fate in aging and Alzheimer's disease. J Comp Neurol.